Inventor · disambiguated record
Kai Liu
Also filed as: LIU KAI · LIU KAI-LUN
39 granted patents·27 pending applications·240 citations·filing 2011–2025
97Inventor score
Files withINCYTE CORP29BEIJING TIDE PHARMACEUTICAL CO LTD9CRYSTAL PHARMACEUTICAL SUZHOU CO LTD5CRYSTAL PHARMATECH CO LTD5JIANGSU HENGRUI MEDICINE CO5
Top patents by PatentIndex Score
66 records- 0198US11407749B2Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2020·Granted Aug 9, 2022·23 cites·24 claims
- 0297US11542265B2Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2021·Granted Jan 3, 2023·8 cites·43 claims
- 0397US11242343B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2020·Granted Feb 8, 2022·12 cites·27 claims
- 0497US10934288B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2019·Granted Mar 2, 2021·13 cites·8 claims
- 0597US10435405B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2018·Granted Oct 8, 2019·23 cites·16 claims
- 0696US10722495B2Cyanoindazole compounds and uses thereofINCYTE CORP·Filed 2018·Granted Jul 28, 2020·24 cites·21 claims
- 0796US10266530B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2017·Granted Apr 23, 2019·24 cites·42 claims
- 0895US11919918B2P2X3 andor P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2022·Granted Mar 5, 2024·6 cites·20 claims
- 0995US11891388B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2021·Granted Feb 6, 2024·3 cites·30 claims
- 1095US11406624B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2019·Granted Aug 9, 2022·9 cites·16 claims
- 1195US10899755B2Benzothiazole compounds and uses thereofINCYTE CORP·Filed 2019·Granted Jan 26, 2021·15 cites·39 claims
- 1294US11866426B2Benzothiazole compounds and uses thereofINCYTE CORP·Filed 2020·Granted Jan 9, 2024·3 cites·41 claims
- 1394US10280164B2Pyrazolopyridone compounds and uses thereofINCYTE CORP·Filed 2017·Granted May 7, 2019·24 cites·38 claims
- 1493US12384778B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2023·Granted Aug 12, 2025·1 cites·49 claims
- 1593US11795166B2Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2021·Granted Oct 24, 2023·2 cites·26 claims
- 1693US11390609B2Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2018·Granted Jul 19, 2022·12 cites·28 claims
- 1792US11767323B2Tricyclic pyridone compounds as JAK2 V617F inhibitorsINCYTE CORP·Filed 2021·Granted Sep 26, 2023·3 cites·37 claims
- 1892US11014929B2Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2019·Granted May 25, 2021·12 cites·54 claims
- 1989US11414444B2P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2018·Granted Aug 16, 2022·5 cites·15 claims
- 2085US11958861B2Spirocyclic lactams as JAK2 V617F inhibitorsINCYTE CORP·Filed 2022·Granted Apr 16, 2024·1 cites·61 claims
- 2185US11661422B2Tricyclic urea compounds as JAK2 V617F inhibitorsINCYTE CORP·Filed 2021·Granted May 30, 2023·1 cites·55 claims
- 2284US9994579B2Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of saltCRYSTAL PHARMATECH CO LTD·Filed 2015·Granted Jun 12, 2018·3 cites·10 claims
- 2383US10610529B2Trabectedin-inclusive injectable pharmaceutical composition for gastrointestinal external use and a method for manufacturing the sameJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Apr 7, 2020·2 cites·18 claims
- 2483US8796474B1Macrolide compounds and methods and intermediates useful for their preparationWILLIAMS LAWRENCE J·Filed 2011·Granted Aug 5, 2014·11 cites·4 claims
- 2580US12509479B2P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2024·Granted Dec 30, 2025·0 cites·17 claims
- 2676US2025326957A1Hot melt adhesive for protecting edge of pole piece, preparation method thereof and protection method thereofSTEADYCHEM SHANGHAI CO LTD·Filed 2025·Application pending·0 cites
- 2774US12071579B1Carbon-based microorganism electronic diverter material and preparation method and use thereofINST OF ECO ENVIRONMENTAL AND SOIL SCIENCES GUANGDONG ACADEMY OF SCIENCES·Filed 2023·Granted Aug 27, 2024·0 cites·14 claims
- 2870US2025206734A1Bicyclic heterocycles as mrgprx2 antagonistsINCYTE CORP·Filed 2024·Application pending·0 cites
- 2967US2025084063A1Bicyclic heterocycles as mrgprx2 antagonistsINCYTE CORP·Filed 2024·Application pending·0 cites
- 3065US2019315743A1Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2019·Application pending·0 cites
- 3164US2025092044A1Kinase InhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 3264US2025092043A1Kinase Inhibitors and DegradersINCYTE CORP·Filed 2024·Application pending·0 cites
- 3363US11697595B2Iron-carbon composite material, preparation method thereof and use thereforINST OF ECO ENVIRONMENTAL AND SOIL SCIENCES GUANGDONG ACADEMY OF SCIENCES·Filed 2021·Granted Jul 11, 2023·0 cites·20 claims
- 3463US2025084087A1Bicyclic heterocycles as mrgprx2 antagonistsINCYTE CORP·Filed 2024·Application pending·0 cites
- 3562US2023030115A1Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 3662US2025115654A1Pharmaceutical composition of glp-1 receptor and gip receptor dual agonist, and use thereofFUJIAN SHENGDI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 3762US2019144439A1Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2018·Application pending·0 cites
- 3860US2018072718A1Pyrazolopyridine compounds and uses thereofINCYTE CORP·Filed 2017·Application pending·0 cites
- 3960US2025236567A1Glomus versiforme (gv) microbial fertilizer, and preparation method and use thereofUNIV LUDONG·Filed 2024·Application pending·0 cites
- 4058US2025289826A1Plpro protein inhibitor, and preparation method and application thereofUNIV TSINGHUA·Filed 2023·Application pending·0 cites
- 4158US2025129543A1Method for growing zinc-catecholate frameworks on bio-fibers and their electronic applicationsUNIV QINGDAO·Filed 2022·Application pending·0 cites
- 4257US12365665B2Solid form of diaminopyrimidine compound or hydrate thereof, preparation method therefor, and application thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2020·Granted Jul 22, 2025·0 cites·25 claims
- 4357US10442800B2Crystal forms of NBI-98854, preparation method and use thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2017·Granted Oct 15, 2019·0 cites·14 claims
- 4457US2017107216A1Heterocyclic compounds as immunomodulatorsINCYTE CORP·Filed 2016·Application pending·0 cites
- 4556US10544129B2Crystalline forms of AP26113, and preparation method thereofCRYSTAL PHARMATECH CO LTD·Filed 2017·Granted Jan 28, 2020·0 cites·14 claims
- 4653US10633376B2Crystalline forms of JAK1-selective inhibitor, processes for preparation and use thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2017·Granted Apr 28, 2020·0 cites·21 claims
- 4753US10626135B2Crystal forms of sodium-glucose co-transporter inhibitor, processes for preparation and use thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2017·Granted Apr 21, 2020·0 cites·5 claims
- 4853US2018072741A1Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2017·Application pending·0 cites
- 4952US10308641B2Crystal form of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxole-5-yl)cyclopropane formamido)-3-methylpyridine-2-yl)benzoic acid and preparation method thereofCRYSTAL PHARMATECH CO LTD·Filed 2016·Granted Jun 4, 2019·0 cites·8 claims
- 5050US11801252B2Pharmaceutical compositionJIANGSU HENGRUI MEDICINE CO·Filed 2022·Granted Oct 31, 2023·0 cites·21 claims
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kai Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →